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O B J E C T I V E S The purpose of this study was to correlate adverse events at long-term follow-up in
patients after an acute coronary syndrome with coronary plaque characteristics derived from simulta-
neous evaluation of their mechanical and compositional properties using virtual histology (intravascular
ultrasound virtual histology) and palpography.
B A C KG ROUND Fibroatheroma is the plaque morphology with the highest risk of causing adverse
cardiac events. Palpography can potentially assess the local mechanical plaque properties with the
possibility of identifying ﬁbroatheroma with the highest risk of rupture.
METHOD S A total of 114 patients with acute coronary syndrome from the PROSPECT (Providing
Regional Observations to Study Predictors of Events in the Coronary Tree) trial underwent a single
ultrasound imaging investigation of their 3 coronary vessels with the co-registration of intravascular
ultrasound virtual histology and palpography. Major adverse cardiac events (MACE) (cardiac death,
cardiac arrest, myocardial infarction, or unstable or progressive angina) were collected up to a median
follow-up of 3.4 years and adjudicated to originally treated culprit versus untreated nonculprit lesions.
R E S U L T S In total, 488 necrotic core–rich plaques were identiﬁed and subclassiﬁed as thin-cap
ﬁbroatheroma (n  111), calciﬁed thick-cap ﬁbroatheroma (n  213), and noncalciﬁed thick-cap ﬁbroathe-
roma (n  164) and matched to their co-registered palpography data. A total of 16 MACE, adjudicated to
untreated nonculprit lesions, were recorded at follow-up. In patients in whom MACE developed, ﬁbroathe-
roma were larger (plaque area 10.0 mm2 [range: 8.4 to 11.6 mm2] vs. 8.2 mm2 [range: 7.7 to 8.8 mm2] (p 0.03)
comparedwith patientswhowereMACE free. By palpography, themaximumand the density strain values did not
differ between the varying subtypes of ﬁbroatheroma of patients with or without MACE during follow-up.
CONC L U S I O N S In acute coronary syndromes, patients treated with stents and contemporary
pharmacotherapy, palpography did not provide additional diagnostic information for the identiﬁcation
of ﬁbroatheroma with a high risk of rupture and MACE during long-term follow-up. (Providing Regional
Observations to Study Predictors of Events in the Coronary Tree [PROSPECT]: An Imaging Study in
Patients With Unstable Atherosclerotic Lesions; NCT00180466) (J Am Coll Cardiol Img 2012;5:S19–27)
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S20In the modern era of cardiology, the
prevention of coronary events through
identification of coronary plaques at
high risk of events has become a topic of
intense research. Several anatomopatho-
logic studies previously showed that most
atherosclerotic plaques responsible for acute
See page S39
coronary syndromes (ACS) are angio-
graphically mild (1,2). The thrombosis
associated with rupture of a thin-cap fi-
broatheroma (TCFA) is the most common
cause of myocardial infarction and cardiac
death (3–6). Moreover, the degree of me-
chanical strain exhibited by the plaque is
related to the thickness of the cap (7,8).
In patients with ACS recruited in the
PROSPECT (Providing Regional Observa-
tions to Study Predictors of Events in the
Coronary Tree) study (9–16), intravascular
ultrasound virtual histology (IVUS-VH)
demonstrated that the plaques responsible
for major adverse cardiac events (MACE),
at a median term follow-up of 3.4 years,
had a larger plaque burden and smaller lumen area
and/or were mostly virtual histology (VH) TCFAs.
IVUS palpography is a technique that can allow
the assessment of local mechanical tissue properties,
with previous in vitro studies suggesting a high
sensitivity and specificity for detecting vulnerable
plaques (17–19). In a subgroup of patients from the
PROSPECT trial, in whom combined IVUS-VH
and palpography recordings were performed, we
explored the potential relationship between the
mechanical and compositional properties of fibro-
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M E T H O D S
Population. The study design of the PROSPECT
rial has been published (9,10). Briefly, this multi-
enter, prospective, international study was de-
igned to identify imaging and serologic predictors
f vulnerable plaque events in patients who under-
ent percutaneous coronary intervention for ACS.
fter treatment of their culprit lesions, patients
nderwent 3-vessel gray-scale IVUS and IVUS-VH
maging of culprit and nonculprit arteries. The
ain inclusion criteria were: 1) acute cardiac pain or
ngina equivalent consistent with unstable angina
r myocardial infarction lasting10 min within the
ast 72 h; and 2) the presence of any of the
ollowing: increased biochemical markers of myo-
ardial necrosis (creatine kinase-myocardial band
soenzyme or troponin I or T) greater than the
pper limits of normal; ST-segment depression 1
m in 2 contiguous leads or transient ST-
egment elevation 1 mm in 2 contiguous leads
asting 30 min; or ST-segment elevation myocar-
ial infarction with onset 24 h previously, diag-
osed with the typical triad of nitrate-unresponsive
hest pain lasting 30 min, ST-segment elevation
1 mm in 2 contiguous leads, or new left bundle
ranch block. This study was approved by the
nstitutional review boards of the centers where the
rocedures were performed. Written informed con-
ent was obtained from all patients before cardiac
atheterization. Clinical follow-up was undertaken
t 30 days, 6 months, and then yearly for at least 2
ears. The study was terminated after all patients
eached a 3-year follow-up.
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ACS acute coronary
syndromes
CSA cross-sectional area
CTFA calcified thick-cap
fibroatheroma
EEM external elastic
embrane
sCRP high-sensitivity C-
reactive protein
IVUS-VH intravascular
ultrasound virtual histology
IVUS intravascular ultraso
MACEmajor adverse card
event(s)
NC necrotic core
NCTFA noncalcified thick-
fibroatheroma
NSTEMI non–ST-segment
elevation myocardial infarct
ROC Rotterdam classificat
STEMI ST-segment elevat
myocardial infarction
TCFA thin-cap fibroatherober 16, 2010, accepted February 14, 2011.
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S21Radiofrequency IVUS analysis. Radiofrequency IVUS
of the left main and proximal 6 to 8 cm of each
major epicardial coronary artery using a phased-
array, 20-MHz, 3.2-F catheter (Eagle Eye, Volcano
Corporation, Rancho Cordova, California) were
performed. During motorized catheter pullback, at
0.5 mm/s, gray-scale IVUS was recorded, and raw
radiofrequency data capture was gated to the R
wave (In-Vision Gold, Volcano Corporation). Ra-
diofrequency IVUS uses spectral (frequency) anal-
ysis as well as amplitude data from the IVUS signal,
which has been correlated with histologic samples
with high sensitivity and specificity (20,21).
All baseline IVUS images were prospectively
offline analyzed at independent core laboratory
without knowledge of subsequent events (Cardio-
vascular Research Foundation, New York, New
York). Radiofrequency IVUS analyses were per-
formed using: 1) QCU-CMS software (Medis,
Leiden, the Netherlands) for contouring; 2) pcVH
2.1 software (Volcano Corporation) for contouring
and data output; and 3) proprietary qVH software
(Cardiovascular Research Foundation) for segmen-
tal qualitative assessment and quantitative data
Figure 1. Subclassiﬁcation of Fibroatheromas
Subclassiﬁcation of ﬁbroatheromas according to the presence of a
respect to the necrotic core. CTFA  calciﬁed thick-cap ﬁbroathero
thick-cap ﬁbroatheroma; TCFA  thin-cap ﬁbroatheroma; THFA  thickoutput. External elastic membrane (EEM) and
lumen borders were contoured for all recorded
frames (each 0.4 mm in length). Quantitative
IVUS measurements included EEM cross-sectional
area (CSA), lumen CSA, plaque and media (EEM
minus lumen) CSA, plaque burden (plaque and
media divided by EEM CSA), and minimal lumen
area. Radiofrequency IVUS plaque components
were color coded as dense calcium (white), necrotic
core (NC) (red), fibrofatty (light green), and fibrotic
tissue (dark green) and reported as percentages of
total plaque area. A lesion was defined as a segment
with 3 consecutive frames with 40% plaque
urden. Only the NC-rich plaques, FA, and TCFAs
ere considered in this study. Because calcium
auses attenuation of the backscattering signal and
ay affect VH-IVUS plaque classification, the NC
ehind calcium is more likely to be artifactual.
onsequently, the core laboratory separately cate-
orized plaques with calcium according to its top-
graphic distribution within the plaque. The NC-
ich plaques were therefore classified as: 1) TCFA
hen the fibrous cap was absent; 2) calcified thick
ap fibroatheroma (CTFA) when dense calcium
us cap and the topographic distribution of the dense calcium
DC  dense calcium; NC  necrotic core; NCTFA  noncalciﬁedﬁbro
ma;-cap ﬁbroatheroma.
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S22was located within the NC or at its endoluminal
side; 3) noncalcified TCFA (NCTFA) when dense
calcium was absent or located outside the NC or on
its abluminal side (22,23) (Fig. 1).
IVUS Palpography acquisition and analysis. IVUS
palpography is a technique that allows the assess-
ment of local mechanical tissue properties. At a
defined pressure difference, soft-tissue (e.g., lipid-
rich) components deform more than hard-tissue
components (e.g., fibrous-calcified) (10–12). In
coronary arteries, the tissue of interest is the vessel
wall, whereas the blood pressure, with its physio-
logic changes during the heart cycle, is used as the
excitation force. Radiofrequency data obtained at
different pressure levels are compared to determine
the local tissue deformation.
Each palpogram represents the strain informa-
tion for a certain cross section over the full cardiac
cycle. The longitudinal resolution of the acquisi-
tions depends on heart rate and pullback speed.
With a heart rate of 60 beats/min and a pullback
speed of 1.0 mm/s, the longitudinal resolution is
1.0 mm. Palpograms were acquired simultane-
ously with radiofrequency IVUS using the same
20-MHz phased-array IVUS catheter. Digital
radiofrequency data were acquired using a
custom-designed workstation.
Data were acquired from the left main and
proximal 6 to 8 cm of each major epicardial coro-
nary artery at a pullback speed of 1.0 mm/s using an
automated pullback device (Trak Back II, Volcano
Corporation) with simultaneous recordings of the
electrocardiogram, aortic pressure, and IVUS-VH
Palpography and IVUS-VH
e view of palpography (left) and IVUS-VH (right) for a TCFA.
spots on palpography are present at the edges of the plaque.
the time of acquisition of the images for both techniques is the
-VH  intravascular ultrasound virtual histology; TCFA  thin-capt
ma.data. The data were subsequently stored on a DVD
and sent to the imaging core laboratory for offline
analyses (Cardialysis BV, Rotterdam, the Nether-
lands). The local strain was calculated from the
gated radiofrequency traces using cross-correlation
analyses, displayed and color coded from blue (for
0% strain) through yellow (for 2% strain) via red, as
previously described (19). This color-coded infor-
mation was superimposed on the lumen vessel
boundary of the cross-sectional IVUS image. Using
previously described methodology, plaque strain
values were assigned a Rotterdam classification
(ROC) ranging from I to IV (ROC I, 0% to 0.5%;
ROC II, 0.6% to 0.9%; ROC III, 0.9% to 1.2%;
ROC IV, 1.2%) (8). A region was defined as a
high-strain spot when it had high strain (ROC III
to IV) that spanned an arc of at least 12° at the
surface of a plaque (identified on the IVUS record-
ing) adjacent to low-strain regions (0.5%). The
highest value of strain in the cross section was taken
as the strain level of the spot.
Cross-correlation of the techniques. An independent
xperienced palpography analyst, blinded to the clinical
nformation of all patients, used a color-blinded side-
y-side view of both (palpography and IVUS-VH).
ecause the 2 recordings (electrocardiography-gated
VUS-VH, and nonelectrocardiography-gated pal-
ography) were taken simultaneously from the same
oronary region, the time stamps (i.e., time of
cquisition) of both techniques were used to super-
mpose the palpography strain values over the cor-
nary plaques identified by IVUS-VH (Fig. 2).
hree different palpography endpoints for each
laque were then calculated.
. Endpoint 1 (maximum strain value per plaque):
maximum value of strain spots in the region of
interest
. Endpoint 2 (density of ROC III to IV per
plaque): cumulative strain of the maximum
strain in all ROC III/ROC IV high-strain
spots, normalized by the number of cross
sections
. Endpoint 3 (density of ROC I/IV per plaque):
cumulative strain of the maximum strain in all
ROC I/ROC II/ROC III/ROC IV high-strain
spots, normalized by the number of cross
sections
Clinical endpoint deﬁnitions. The primary endpoint
as MACE, defined as a composite of cardiac
eath, cardiac arrest, myocardial infarction, or un-
table or progressive angina requiring rehospitaliza-Figure 2.
Side-by-sid
High-strain
Note that
same. IVUSion or revascularization. On the basis of follow-up
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S23angiography, MACE were adjudicated as occurring
at the initially treated lesion site responsible for the
original ACS (the index culprit lesion), or at pre-
viously untreated coronary segments (nonculprit
lesions). If follow-up angiography was not per-
formed, the location of the MACE was classified
indeterminate (9,10).
Statistical analysis. Categorical variables are pre-
sented using frequencies and percentages, continuous
variables with mean  SD or median (interquartile
range), according to their normal or non-normal
distribution. Comparison and correlation among
variables were done with different statistical tests
according to their distribution. Analysis of normal-
ity of the continuous variables was performed with
the Kolmogorov-Smirnov test. In particular, com-
parison among groups for variables normally dis-
tributed was performed by analysis of variance and
for variables non-normally distributed by the
Mann-Whitney or Kruskal-Wallis test. Correlation
among variables was done by the Pearson or Spear-
man test, accordingly to their normal or non-
normal distribution, respectively. Palpography end-
points were compared at the plaque level and at the
patient level. To relate high-sensitivity C-reactive
protein (hsCRP) values to plaque type, because
hsCRP is patient specific, each patient was entered
in the analysis, according to his or her worst plaque
(TCFA, CTFA, or NCTFA). For plaque (i.e.,
fibroatheroma) or lesion level data, a model with a
generalized estimating equations approach was used
to compensate for any potential cluster effect of
multiple plaques in the same lesion or multiple
lesions in the same patient and presented as least-
square means with 95% confidential intervals. A
2-sided p value 0.05 indicated statistical signifi-
cance. Statistical analyses were performed using
SPSS software version 13.0 (SPSS Inc., Chicago,
Illinois).
R E S U L T S
Baseline clinical characteristics. Between October 29,
004, and June 8, 2006, the PROSPECT trial
nrolled 697 patients. In a subgroup of 114 patients,
VUS palpography and radiofrequency recordings
ere simultaneously obtained during a single IVUS
ullback. Clinical baseline characteristics are shown
n Table 1. At a median follow-up of 3.4 years, a
otal of 16 MACE were recorded in this popula-
ion, adjudicated to untreated nonculprit lesions.
ecause no death or acute myocardial infarction inhis subgroup occurred during follow-up, MACEherefore consisted mainly of new occurrences of
nstable or progressive angina requiring rehospital-
zation or revascularization.
Imaging analysis. A total of 488 NC-rich plaques
were identified by radiofrequency IVUS and palpog-
Table 1. Patient Characteristics, Baseline Laboratory Results, and
Age, yrs
Female
Diabetes mellitus
Requiring insulin
Metabolic syndrome
Current cigarette use
Hypertension
Hyperlipidemia
Previous myocardial infarction
Family history of coronary artery disease
Framingham risk score
Previous percutaneous coronary intervention
Clinical presentation
ST-segment elevation myocardial infarction
Non–ST-segment elevation myocardial infarction
Unstable angina with electrocardiographic changes
Body mass index, kg/m2
Cholesterol, mg/dl
Total
LDL
HDL
Triglycerides, mg/dl,
Hemoglobin A1c, %,
Estimated creatinine clearance, ml/min
High-sensitivity C-reactive protein, mg/l
Values are mean  SD, n (%), or median (interquartile range).
HDL  high-density lipoprotein; LDL  low-density lipoprotein.
Table 2. Lesion Characterization of Necrotic Core–Rich
Plaques (N  488)
Lumen cross-sectional area, mm2 7.6 3.2
External elastic membrane area, mm2 16.2 5.5
Plaque cross-sectional area, mm2 8.6 3.2
Plaque burden, % 53.5 9.6
70% 37 (7.5)
Fibroatheroma length, mm 1.7 (0.9–3.0)
Tissue composition, %
Fibrotic 29.5 8.1
Fibrofatty 6.7 4.4
Dense calcium 7.0 4.7
Necrotic core 14.1 4.8
Plaque classiﬁcation
Thin-cap ﬁbroatheroma 111 (22.8)
Calciﬁed thick-cap ﬁbroatheroma 213 (43.6)
Noncalciﬁed thick-cap
ﬁbroatheroma
164 (33.6)Index Procedure
55.7 10.9
25/114 (22)
13/114 (11.4)
3/114 (2.6)
31/114 (27.1)
65/114 (57.7)
56/114 (49.1)
62/114 (54.3)
12/114 (10.5)
61/114 (53.5)
6.3 3.1
11/114 (9.6)
44/114 (38.5)
56/114 (49.3)
14/114 (12.2)
28.3 5.1
172.7 42.5
81.4 48.4
43.3 21.1
128.8 84.3
5.8 (5.3–6.1)
104.0 (79.0–132.4)
7.0 (2.4–16.6)Values are mean  SD, n (%), or median (interquartile range).
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S24raphy (4.2 per patient). Table 2 shows all imaging data.
n particular, 22.8% were classified as TCFAs,
3.6% CTFAs, and 33.6% NCTFAs. No differ-
nces were found in palpography endpoints among
hese 3 types of plaque (Table 3).
The hsCRP values did not differ among the
ifferent types of plaque considered at the patient
evel (TCFA, 8.5 mg/l [interquartile range: 3.0 to
2.4 mg/l]; CTFA, 6.9 mg/l [interquartile range:
.8 to 19.4 mg/l]; NCTFA, 8.5 mg/l [interquartile
ange: 4.0 to 19.7 mg/l]; p  0.2). No correlation
as found between palpography endpoints and
sCRP at the patient level (r  0.004, p  0.975
or endpoint #1; r  0.073, p  0.511 for endpoint
2; r  0.46, p  0.678 for endpoint #3).
alpography endpoint #1 was higher in patients with
clinical presentation of ST-segment elevation myocar-
ial infarction (STEMI) or non–ST-segment eleva-
ion myocardial infarction (NSTEMI) compared
ith patients with unstable angina (0.31% [inter-
Figure 3. Maximum Strain Value Distribution According to Clini
The mean of the maximum strain value (endpoint #1) in the necrot
Table 3. Palpography Analysis
TCFA
(n  111)
Maximum strain value (endpoint #1), % 0.56 0.36
0.45 (0.30–0.
Density of ROC III–IV (endpoint #2), ROC/mm 0.08 0.18
0.00 (0.00–0.
Density of ROC I–IV (endpoint #3), ROC/mm 0.31 0.20
0.28 (0.15–0.
Values are mean  SD and median (interquartile range).
CTFA  calciﬁed thick-cap ﬁbroatheroma; NCTFA noncalciﬁed thick-cap ﬁbrsegment elevation myocardial infarction; STEMI  ST-segment elevationuartile range: 0.25% to 0.50%]); NSTEMI (0.60%
interquartile range: 0.37% to 0.70%]); or STEMI
0.50% [interquartile range: 0.32% to 0.76%]) (Fig. 3).
sCRP values did not differ according to the clinical
resentation (unstable angina, 4.5 mg/l [interquar-
ile range: 2.6 to 10.5 mg/l] vs. NSTEMI, 6.6 mg/l
interquartile range: 2.6 to 12.4 mg/l] vs. STEMI,
.1 mg/l [interquartile range: 2.2 to 20.7 mg/l];
 0.418). Comparison of the tertiles of end-
oint 1 in terms of hsCRP values showed no
ifferences among them (7.9 mg/l [interquartile
ange: 3.6 to 13.0 mg/l] vs. 6.6 mg/l [interquar-
ile range: 1.6 to 11.1 mg/l] vs. 8.5 mg/ml
interquartile range: 2.4 to 18.0 mg/l], respec-
ively; p  0.794). The other palpography end-
oints did not differ among patients according to
heir clinical presentation.
Plaques with ROC III to IV showed no differ-
nces compared with plaques with ROC I to II
Table 4). A weak correlation was found between
Presentation
re–rich plaques by clinical presentation. NSTEMI  non–ST-
CTFA
(n  213)
NCTFA
(n  164) p Value
0.53 0.44 0.58 0.44 0.50
0.40 (0.30–0.80) 0.50 (0.30–0.70)
0.09 0.27 0.080.20 0.80
0.00 (0.00–0.00) 0.00 (0.00–0.00)
0.33 0.29 0.33 0.27 0.70
0.25 (0.15–0.42) 0.25 (0.15–0.44)
eroma; ROC  Rotterdam classiﬁcation; TCFA  thin-cap ﬁbroatheroma.cal
ic co70)
00)
40)myocardial infarction; UA  unstable angina.
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S25the palpography endpoint 3 and relative content of
fibrous tissue for the TCFA plaques (r0.2, p
0.02). No correlation was found between the other
palpography endpoints and VH component for
other VH plaque type (CTFA and NCTFA).
The fibroatheromas identified in the patients in
whom MACE developed during follow-up were 49
of 488 (10.0%): TCFA, 11 of 49 (22.4%); CTFA,
22 of 49 (45%), and NCTFA, 16 of 49 (32.6%).
These plaques demonstrated higher areas (p 
0.03) and a higher fibrofatty component (p  0.01)
compared with plaques of patients who were MACE
free during follow-up (Table 5). However, in this
substudy, no differences were found among the groups
according to the distribution of VH plaque classifica-
tion. No differences were found in palpography end-
points between the plaques of patients with or without
MACE during follow-up (Table 5).
D I S C U S S I O N
The principal findings of this substudy are the
following: 1) larger fibroatheromas are confirmed
to be more frequent in patients in whom cardiac
events develop during long-term follow-up; and
2) palpography does not provide any additional
diagnostic information with respect to the VH
and does not specifically identify plaques at
higher risk of events.
The PROSPECT study was the first trial to
study atherosclerosis using a multimodality intra-
coronary imaging approach in patients after suc-
cessfully treated ACS. This demonstrated that non-
culprit lesions with a higher plaque burden and a
radiofrequency IVUS morphology of TCFA were
independent predictors of cardiovascular events
over a 3-year follow-up period (9,11–16).
In our substudy, we focused on NC-rich
plaques and analyzed the palpography data of
Table 4. Comparison of Radiofrequency IVUS Parameters and
ROC Palpography Classiﬁcation
IVUS-VH
ROC I–II
Plaques
(n  404)
ROC III–IV
Plaques
(n  84) p Value
Plaque area, mm2 8.5 (8.0–9.0) 8.2 (7.3–9.1) 0.40
Dense calcium, % 6.3 (5.6–7.0) 6.2 (5.1–7.2) 0.86
Necrotic core, % 12.9 (12.1–13.6) 12.5 (11.5–13.5) 0.44
Fibrous tissue, % 30.2 (28.9–31.4) 29.3 (27.1–31.5) 0.59
Fibrofatty tissue, % 7.2 (6.5–8.0) 7.53 (6.3–8.6) 0.59
All values are presented as generalized estimating equation–adjusted least
mean square (95% conﬁdence interval).
IVUS  intravascular ultrasound; IVUS-VH  intravascular ultrasound virtual
histology; ROC  Rotterdam classiﬁcation.these plaques. As shown in the main study, wefound that larger fibroatheromas were more fre-
quent in patients in whom events developed
during follow-up. It is noteworthy to consider
that, because previous studies demonstrated a
correlation between plaque size and its NC con-
tent (24,25), use of gray-scale IVUS could be
sufficiently powerful to identify larger and NC-
rich plaques. In this substudy, no difference,
indeed, was demonstrated in VH plaque distri-
bution between plaques of patients in whom
MACE developed during follow-up and those
who were MACE free.
Palpography was previously shown to poten-
tially detect differences in deformability (strain)
exhibited by different types of plaques, with
lipid-rich plaques deforming more and thus
showing a higher strain value compared with
calcified or fibrous plaques (17,19). Rodriguez-
Granillo et al. (8) showed that IVUS-VH had an
acceptable sensitivity to detect high strain as
assessed by palpography, but a low specificity.
However, all of these studies were performed
retrospectively and could not identify the predic-
tive value of these techniques in the detection of
high-risk plaques. In our subanalysis of the
PROSPECT trial, palpography analyses of all 3
coronary vessels were performed and all data were
matched to each NC-rich plaque. Our approach
was therefore plaque based, whereas Rodriguez-
Granillo et al. (8) used a frame-based approach.
Using this plaque-based approach, we found
that ROC III to IV plaques did not exhibit any
difference in VH composition compared with
ROC I to II plaques, confirming the results of
our previous frame-based approach (8). In addi-
tion, palpography was already validated in an ex
vivo model to identify thin-capped fibroathero-
mas. However, in this substudy, the strain values
were found to be no different between plaques
with a thin or a thick fibrous cap, as evaluated by
IVUS (19,26,27).
The number of high-strain spots in the culprit
epicardial vessel was previously found to be cor-
related with clinical presentation and significantly
decrease with standard medical therapy (18). In
our analysis, we confirmed that the high-strain
spot can be correlated with the clinical presenta-
tion, finding a higher maximum strain value in
patients with a clinical presentation of NSTEMI
or STEMI compared with those with unstable
angina (18) (Fig. 3). However, we did not achieve
any correlation between the high-strain spot and
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S26the C-reactive protein values, as found in a
previous study (18).
It is important to highlight that the strain
values of palpography were lower in our popula-
tion compared with previous studies (8,27); these
low strain values may be the reason for the low
rates of cardiac events recorded in our population.
Palpography can, indeed, potentially identify
some of the mechanical properties of coronary
plaques that are more prone to rupture and lead
to a clinical event such as cardiac death or acute
myocardial infarction (18,19). However, during
the follow-up, no patients experienced either
cardiac death or myocardial infarction, only pro-
gressive stable or unstable angina. For these
reasons, our study, therefore, may have been
underpowered to detect possible differences in
the mechanical properties of coronary plaques
more prone to cause serious cardiac events (car-
diac death, cardiac arrest, or myocardial infarc-
tion). The low rate of events confirms the results
of the main trial in which the 3-year rate of
serious adverse events was 4.9%, attesting to the
favorable outcomes that may be achieved in this
population with high compliance with medical
therapy and close clinical follow-up (9).
Study limitations. The main limitations are the
small sample size and the low event rate at follow-
Table 5. Comparison of Coronary Plaques in Patients With and
Plaques in Pati
(n 
Radiofrequency IVUS*
Plaque area, mm2 10.0 (8
Dense calcium, % 6.3 (5
Necrotic core, % 12.4 (1
Fibrous tissue, % 32.6 (2
Fibrofatty tissue, % 10.3 (7
VH plaque classiﬁcation
TCFA 11 (2
CTFA 22 (4
NCTFA 16 (3
Palpography
Maximum strain value (endpoint #1), % 0.51
0.40 (0
Density of ROC III–IV (endpoint #2), ROC/mm 0.06
0.00 (0
Density of ROC I–IV (endpoint #3), ROC/mm 0.30
0.29 (0
Values are n (%), mean  SD, or median (interquartile range). *These values a
conﬁdence interval).
MACE  major adverse cardiac event; VH  virtual histology; other abbreviatup. IVUS has an axial resolution of 100 to 200 m, phereas the pathologic definition of TCFA typi-
ally requires a cap thickness 65 m (3). As such,
proportion of the lesions classified as TCFAs by
adiofrequency IVUS were more likely to have had
hick fibrous caps. At present, no data are available
o show that that IVUS-VH could be used to make
reatment decisions.
C O N C L U S I O N S
Our data confirm that larger fibroatheromas oc-
cur more frequently in patients in whom cardiac
events develop during long-term follow-up, al-
though no statistical differences in VH plaque
classification were found between patients with or
without MACE. However, a combined approach
by IVUS-VH and palpography did not lead to
any additional information with regard to aiding
diagnostic identification of the fibroatheroma
with the higher risk of rupture. In light of these
results, the future application of palpography as
an intracoronary imaging device to detect high-
risk lesions needs to be revisited.
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